View All
| Feature | Specification |
|---|---|
| Application | Protein Quantification |
| Dynamic Range | 0.92 - 300,000 pg/mL |
| Limit of Detection | 0.92 pg/ml |
| Limit of Quantification | 3.12 pg/ml |
| Sample Volume | 10 µL |
Formats:
Features:
Vascular Cell Adhesion Molecule-1 (VCAM-1) is a transmembrane glycoprotein with a molecular weight of 110 kDa. VCAM-1 contains six to seven immunoglobulin domains and is expressed on vascular endothelial cells of both small and large blood vessels after stimulation via cytokines (i.e. TNFα, IL-4). It mediates immune system response by recruiting additional immune cells to sites of inflammation. After VCAM-1 binds to either Very Late Antigen 4 (VLA-4) or Integrin receptor α4β7 a proteolytic ectodomain shedding process triggers the release of a soluble form of VCAM-1 (sVCAM-1). This soluble form can be utilized as an inflammatory biomarker. Serum levels of sVCAM-1 have been found to be altered in patients with cancer, diabetes, atherosclerosis, rheumatoid arthritis, and other autoimmune diseases. The AlphaLISA kit presented here detects sVCAM-1 in serum, plasma, and cell culture media.
AlphaLISA technology allows the detection of molecules of interest in a no-wash, highly sensitive, quantitative assay. In an AlphaLISA assay, a biotinylated anti-analyte antibody binds to the Streptavidin-coated Donor beads while another anti-analyte antibody is conjugated to AlphaLISA Acceptor beads. In the presence of the analyte, the beads come into close proximity. The excitation of the Donor beads causes the release of singlet oxygen molecules that triggers a cascade of energy transfer in the Acceptor beads, resulting in a sharp peak of light emission at 615 nm.
The AlphaLISA assay is based on an AlphaLISA sandwich immunoassay involving a biotinylated anti-analyte antibody bound to Streptavidin-coated AlphaLISA Donor beads and an anti-analyte antibody conjugated to AlphaLISA Acceptor beads. Both antibodies are directed against the analyte of interest. In the presence of the target, both antibodies bind to analyte and the beads come into proximity. The excitation of the Donor beads provokes the release of singlet oxygen molecules that triggers a cascade of energy transfer within the Acceptor beads, resulting in emission with λmax at 615 nm. The intensity of the signal is directly proportional to the concentration of analyte present in the sample.
The AlphaLISA assay can be run in a 96- or 384-well detection plate (50 µL final). As described here, samples or standards are dispensed directly into the assay plate for the detection of the analyte of interest by AlphaLISA reagents. No washing steps are needed. The protocol can be further miniaturized or upscaled by simply resizing each addition volume proportionally.
| Application |
Protein Quantification
|
|---|---|
| Automation Compatible |
Yes
|
| Brand |
AlphaLISA
|
| Detection Modality |
Alpha
|
| Dynamic Range |
0.92 - 300,000 pg/mL
|
| Limit of Detection |
0.92 pg/ml
|
| Limit of Quantification |
3.12 pg/ml
|
| Product Group |
Kit
|
| Sample Volume |
10 µL
|
| Shipping Conditions |
Shipped in Blue Ice
|
| Target |
VCAM-1
|
| Target Class |
Biomarkers
|
| Target Species |
Human
|
| Technology |
Alpha
|
| Therapeutic Area |
Oncology
|
| Unit Size |
100 assay points
|
Are you looking for resources, click on the resource type to explore further.
Loading...
We are here to answer your questions.